InVivo Therapeutics Holdings Corp.

Equities

NVIV

US46186M6057

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 02:17:31 2024-04-18 pm EDT			5-day change	1st Jan Change
0.369 ^USD	-1.13%		-0.27%	-49.45%

Apr. 16	North American Morning Briefing : Powell Comments, -2-	DJ
Apr. 02	North American Morning Briefing : Stocks Seen -2-	DJ

Invivo Therapeutics Holdings Corp. Reports Earnings Results for the Full Year Ended December 31, 2020

March 01, 2021 at 04:09 pm EST

InVivo Therapeutics Holdings Corp. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced operating loss was USD 9.097 million compared to USD 11.497 million a year ago. Net loss was USD 9.074 million compared to USD 11.830 million a year ago. Basic loss per share from continuing operations was USD 1.31 compared to USD 35.28 a year ago.

Latest news about InVivo Therapeutics Holdings Corp.

North American Morning Briefing : Powell Comments, -2-	Apr. 16	DJ
North American Morning Briefing : Stocks Seen -2-	Apr. 02	DJ
North American Morning Briefing : Markets Steady -2-	Mar. 26	DJ
North American Morning Briefing : Stock Futures -2-	Mar. 19	DJ
InVivo Therapeutics Holdings Corp.(OTCPK:NVIV.Q) dropped from NASDAQ Composite Index	Feb. 11	CI
InVivo Therapeutics Holdings Corp.(NasdaqCM:NVIV) dropped from S&P TMI Index	Feb. 06	CI
Motion for Joint Administration Approved for Invivo Therapeutics Corporation	Feb. 05	CI
Motion for Asset Sale Filed by Invivo Therapeutics Corporation	Jan. 31	CI
Motion for Joint Administration Filed by Invivo Therapeutics Corporation	Jan. 31	CI
Invivo Therapeutics Corporation Filed for Bankruptcy	Jan. 31	CI
Invivo Therapeutics Holdings Corp. Announces Resignation of Daniel R. Marshak from the Board of Directors	Nov. 22	CI
InVivo to open Saudi office as adapts to global grain shifts	Nov. 15	RE
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Australia's United Malt agrees to $1 bln takeover offer from France's InVivo	23-07-02	RE
Trio of French businessmen plan counter-offer for Casino	23-06-08	RE
Trio of French businessmen plan counter-offer for Casino	23-06-08	RE
InVivo Therapeutics Holdings Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
France's InVivo offers close to $1 bln for Australia's United Malt	23-03-27	RE
France's InVivo placed bid for Australia's United Malt -report	23-03-27	RE
Sector Update: Healthcare Stocks Stumble Late	23-03-09	MT
Sector Update: Health Care	23-03-09	MT
Top Midday Decliners	23-03-09	MT
InVivo Therapeutics Says Study of Neuro-Spinal Scaffold Device Didn't Achieve Primary Endpoint; Shares Fall	23-03-09	MT
InVivo Therapeutics Says Study of Neuro-Spinal Scaffold Device Didn't Achieve Primary Endpoint; Shares Halted	23-03-09	MT

Chart InVivo Therapeutics Holdings Corp.

Duration

Period

Chart InVivo Therapeutics Holdings Corp.

More charts

Company Profile

InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by-side, healing by supporting the surrounding tissue after injury, minimizing the expansion of areas of necrosis, and providing a biomaterial substrate for the body's own healing/repair processes following injury. It is composed of two biocompatible and bioresorbable polymers that are cast to form a porous investigational product: Poly lactic-co-glycolic acid and Poly-L-Lysine. Poly lactic-co-glycolic acid is a polymer that is used in resorbable sutures and provides biocompatible support for Neuro-Spinal Scaffold implants and Poly-L-Lysine is a positively charged polymer used to coat surfaces.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INVIVO THERAPEUTICS HOLDINGS CORP.	-49.45%	1.16M
THERMO FISHER SCIENTIFIC	+2.02%	209B
DANAHER CORPORATION	+2.17%	177B
INTUITIVE SURGICAL, INC.	+10.45%	133B
BOSTON SCIENTIFIC CORPORATION	+16.62%	99.89B
SIEMENS HEALTHINEERS AG	-2.70%	61.83B
EDWARDS LIFESCIENCES CORPORATION	+13.38%	52.51B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.33%	45.54B
AGILENT TECHNOLOGIES, INC.	-4.74%	39.43B
GE HEALTHCARE TECHNOLOGIES INC.	+9.89%	38.87B

Other Advanced Medical Equipment & Technology